KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Shares Outstanding (2016 - 2025)

Edwards Lifesciences (EW) has 14 years of Shares Outstanding data on record, last reported at $642.9 million in Q1 2022.

  • For Q1 2022, Shares Outstanding rose 0.85% year-over-year to $642.9 million; the TTM value through Mar 2022 reached $642.9 million, up 0.85%, while the annual FY2021 figure was $642.0 million, 0.88% up from the prior year.
  • Shares Outstanding reached $642.9 million in Q1 2022 per EW's latest filing, roughly flat from $642.0 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $642.9 million in Q1 2022 and bottomed at $2.3 million in Q1 2018.
  • Average Shares Outstanding over 5 years is $206.8 million, with a median of $17.0 million recorded in 2021.
  • The widest YoY moves for Shares Outstanding: up 9291.3% in 2019, down 95.79% in 2019.
  • A 5-year view of Shares Outstanding shows it stood at $7.5 million in 2018, then soared by 2808.0% to $218.1 million in 2019, then surged by 191.79% to $636.4 million in 2020, then grew by 0.88% to $642.0 million in 2021, then increased by 0.14% to $642.9 million in 2022.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $642.9 million in Q1 2022, $642.0 million in Q4 2021, and $641.2 million in Q3 2021.